FDA Mandates New Pediatric Labeling for Inhaled, Intranasal Corticosteroids
The long-term effects on final adult height are unknown and it also has not been determined if growth rate will catch up once treatment is discontinued.
Approximately a dozen products will be relabeled to carry this new information. Drug manufacturers will continue to monitor these drugs to learn more about long-term effects. For more on the talk paper, click here. For more information about class labeling, click here.